Details for 2019884611

Up to date per 03.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN DES P2X3-MODULATORS METHYL (S)-2-((2-(2,6-DIFLUORO-4-(METHYLCARBAMOYL )PHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHYL)MORPHOLIN-4-CARBOXYLAT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019884611

EP Publication Number

3880678

E-Number

1792398

Language

PCT Number

IB19001199

Publication Date

22.09.2021 A

07.05.2025 B1

Registration Date

07.05.2025

AT Publication Date

15.05.2025

Application Date

12.11.2019

Registration Number

Priorities

13.11.2018

201862760307 P

IPC

C07D 471/04 20060101AFI20220727BHEP

Maximum Duration of Protection

12.11.2039

Owner

GlaxoSmithKline Intellectual Property (No.3) LimitedGSK Medicines Research Centre Gunnels Wood Road Stevenage SG1 2NYGB

Representative

No representatives present

Inventor

GARCEAU, Denis275, Boulevard Armand-frappier Laval, QC H7V 4A7CA

WENSLOW, Robert M.275, Boulevard Armand-frappier Laval, QC H7V 4A7CA

PAYZA, Kemal275, Boulevard Armand-frappier Laval, QC H7V 4A7CA

CHAURET, Nathalie275, Boulevard Armand-frappier Laval, QC H7V 4A7CA

Information about Fees